Literature DB >> 482856

The physiologic basis for clearance measurements in hepatology.

K Winkler, L Bass, S Keiding, N Tygstrup.   

Abstract

Three hepatic clearance regimes (flow-limited, general, and enzyme-limited) can be defined from a model of hepatic perfusion-elimination relationships. Substances that can be used for clearance measurements can thus be classified into three categories according to the relation between their kinetic elimination constants (Vmax, Km) and hepatic blood flow. The pathophysiologic and clinical importance of the clearance regimes is discussed with special emphasis on the effect of changes in hepatic blood flow and liver function. The criteria for choosing test substances within each regime are stated. This choice depends on the object of study for a clearance measurement (blood flow, drug elimination, liver function). Only the enzyme-limited clearance regime is suited for direct assessment of quantitative liver function ('true clearance'), while the other regimes depend more or less on blood flow.

Mesh:

Year:  1979        PMID: 482856

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  16 in total

1.  Can intrahepatic shunting be measured?

Authors:  S Keiding
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

Review 2.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

Review 3.  Clinical significance of pharmacokinetic models of hepatic elimination.

Authors:  D J Morgan; R A Smallwood
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

4.  Pharmacokinetic studies of DISIDA disposition. I. Animal studies.

Authors:  I A Fraser; P Shaffer; J Love; A E Staubus; G Hinkle; J Olsen; L C Carey; P J Fabri; E C Ellison
Journal:  Eur J Nucl Med       Date:  1988

5.  Hepatic clearance of D-sorbitol. Noninvasive test for evaluating functional liver plasma flow.

Authors:  G Molino; A Cavanna; P Avagnina; M Ballaré; M Torchio
Journal:  Dig Dis Sci       Date:  1987-07       Impact factor: 3.199

6.  Hemodynamic differences between alcoholic and nonalcoholic cirrhotics following distal splenorenal shunt--effect on survival?

Authors:  J M Henderson; W J Millikan; L Wright-Bacon; M H Kutner; W D Warren
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969

Review 7.  Quantitative PET of liver functions.

Authors:  Susanne Keiding; Michael Sørensen; Kim Frisch; Lars C Gormsen; Ole Lajord Munk
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

8.  Endogenous bile acid tolerance test for liver function.

Authors:  M van Blankenstein; M Frenkel; J W van den Berg; F J ten Kate; E P Bosman-Jacobs; A C Touw-Blommesteyn
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

9.  Regional metabolic liver function measured in patients with cirrhosis by 2-[¹⁸F]fluoro-2-deoxy-D-galactose PET/CT.

Authors:  Michael Sørensen; Kasper S Mikkelsen; Kim Frisch; Gerda E Villadsen; Susanne Keiding
Journal:  J Hepatol       Date:  2013-01-20       Impact factor: 25.083

10.  Hepatic ethanol elimination kinetics in patients with cirrhosis.

Authors:  Gitte Dam; Michael Sørensen; Ole Lajord Munk; Susanne Keiding
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.